Micromem Technologies Inc. Interim Filings TORONTO and NEW

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Micromem Technologies Inc. Interim Filings

TORONTO and NEW YORK, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Micromem Technologies Inc. (the "Company") (CNSX: MRM ) (OTCBB: MMTIF ) announces it has filed its interim financial statements for the period ended July 31, 2013, together with the Management's Discussion & Analysis ("MD&A") on SEDAR and EDGAR today. These documents may be viewed at www.sedar.com and by searching EDGAR at http://www.sec.gov/ .

In the MD&A documentation filed, management has provided a recap of the progress made on its four significant current opportunities with its customers. Management reports in the MD&A that the analysis that it has completed for these initial four market applications is that, collectively, once these units are in commercial production, the Company's revenue opportunities could be in the hundreds of millions of dollars. Additionally, beyond these initial opportunities, management reports that the proposal pipeline that it continues to develop is robust and growing.

Management reports, in the MD&A, an analysis of the expenditures made and financing raised since November 2007 when the Company began the research, development and commercialization of its customized applications and solutions for large international corporations based on its proprietary magnetic sensor technology. Since November 2007, the Company has raised and deployed approximately $19 million (USD) of financing to support this activity and the Company's working capital requirements.

About Micromem and MASTInc

MASTInc is a wholly owned U.S.-based subsidiary of Micromem Technologies Inc., a publicly traded (OTCBB: MMTIF ) (CNSX: MRM ) company. MASTInc responsibly analyzes the specific industry sectors to create intelligent game-changing applications that address unmet market needs. By leveraging its expertise and experience with sophisticated magnetic sensor applications, MASTInc successfully powers the development and implementation of innovative solutions for healthcare/biomedical, natural resource exploration, government, information technology, manufacturing, and other industries. Visit www.micromeminc.com www.mastinc.com .

Safe Harbor Statement

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward looking statements include: our inability to obtain additional financing on acceptable terms; risk that our products and services will not gain widespread market acceptance; continued consumer adoption of digital technology; inability to compete with others who provide comparable products; the failure of our technology; the infringement of our technology with proprietary rights of third parties; inability to respond to consumer and technological demands; inability to replace significant customers; seasonal nature of our business; and other risks detailed in our filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements. When used in this document, the words "believe," "expect," "anticipate," "estimate," "project," "plan," "should," "intend," "may," "will," "would," "potential," and similar expressions may be used to identify forward-looking statements.

The CNSX or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release that has been prepared by management.

Listing: NASD OTC-Bulletin Board - Symbol: MMTIF

CNSX - Symbol: MRM

Shares issued: 154,981,077

SEC File No: 0-26005

Investor Contact: info@micromeminc.com ; Tel. 416-364-2023

Subscribe to receive News Releases by Email on our website's home page. www.micromeminc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 9

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 17

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 13

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 20

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 19

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 16

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 17

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 11

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Zeta Global Faces Class Action Risks

Updated Category News Views 124

Understanding the Zeta Global Class Action Lawsuit Zeta Global Holdings Corp. finds itself at a pivotal moment as investors are encouraged to take action following significant losses related to the company's stock performance. This situation arises from allegations concerning misleading practices during a specified class period. Investors who purchased or acquired Zeta...

Continue Reading
Belk and Sewing Down South Unveil Exciting Seasonal Collection

Updated Category News Views 592

Belk Introduces Collaborations for Summer and Holiday Lines Belk, a prominent name in department stores, is excited to announce its new partnership with Sewing Down South, a vibrant lifestyle brand founded by Craig Conover. This collaboration is set to redefine Southern fashion, providing customers with an array of stylish options for both summer and the upcoming holiday...

Continue Reading
Explore the Ongoing Securities Investigation of Construction Partners

Updated Category News Views 198

Understanding the Securities Fraud Investigation of Construction Partners, Inc. The Law Offices of Frank R. Cruz are currently conducting an investigation into Construction Partners, Inc. (NASDAQ: ROAD). This inquiry focuses on potential violations of federal securities laws that may have had adverse effects on investors. If you are among those who suffered financial...

Continue Reading
eHealth, Inc. Announces Q3 2025 Earnings Call Details

Updated Category News Views 111

eHealth, Inc. to Share Third Quarter Earnings on November 5 eHealth, Inc. (NASDAQ: EHTH), recognized as a leading private online health insurance marketplace, is gearing up to unveil its financial results for the third quarter of 2025. The announcement is scheduled for November 5, when eHealth will provide comprehensive insights into its performance for investors and...

Continue Reading
Danske Mortgage Bank Set to Release Annual Report Soon

Updated Category News Views 107

Danske Mortgage Bank Plc's Upcoming Annual Report Release Danske Mortgage Bank Plc is gearing up to unveil its much-anticipated annual report for 2025 on a scheduled date that reflects the company's commitment to transparency and financial reporting. This report serves as an essential tool for stakeholders, investors, and analysts who follow the financial performance and...

Continue Reading